NasdaqGS - Delayed Quote USD

Embecta Corp. (EMBC)

10.15 -0.08 (-0.78%)
At close: May 3 at 4:00 PM EDT
10.35 +0.20 (+1.97%)
After hours: May 3 at 4:58 PM EDT
Loading Chart for EMBC
DELL
  • Previous Close 10.23
  • Open 10.43
  • Bid 10.11 x 600
  • Ask 10.17 x 300
  • Day's Range 10.12 - 10.56
  • 52 Week Range 9.93 - 32.00
  • Volume 428,146
  • Avg. Volume 434,516
  • Market Cap (intraday) 584.426M
  • Beta (5Y Monthly) 0.71
  • PE Ratio (TTM) 10.57
  • EPS (TTM) 0.96
  • Earnings Date May 9, 2024
  • Forward Dividend & Yield 0.60 (5.91%)
  • Ex-Dividend Date Feb 27, 2024
  • 1y Target Est 16.50

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

www.embecta.com

2,200

Full Time Employees

September 30

Fiscal Year Ends

Recent News: EMBC

Performance Overview: EMBC

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EMBC
45.82%
S&P 500
7.50%

1-Year Return

EMBC
62.98%
S&P 500
24.47%

3-Year Return

EMBC
--
S&P 500
13.66%

5-Year Return

EMBC
--
S&P 500
13.66%

Compare To: EMBC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMBC

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    584.43M

  • Enterprise Value

    1.92B

  • Trailing P/E

    10.57

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.71

  • Enterprise Value/EBITDA

    9.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.93%

  • Return on Assets (ttm)

    10.21%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.12B

  • Net Income Avi to Common (ttm)

    55.3M

  • Diluted EPS (ttm)

    0.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    298.7M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.96M

Research Analysis: EMBC

Company Insights: EMBC

Research Reports: EMBC

People Also Watch